Guideline Summaries

DIAGNOSIS AND MANAGEMENT OF ACUTE MYELOID LEUKAEMIA IN PREGNANCY

DIAGNOSIS AND MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM DIFFUSE LARGE B‐CELL LYMPHOMA (PCNSL)

DIAGNOSIS AND MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE

DIAGNOSIS, INVESTIGATION AND MANAGEMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA

DIAGNOSIS AND MANAGEMENT OF POLYCYTHAEMIA VERA

MANAGEMENT OF CLASSICAL HODGKIN LYMPHOMA

MANAGEMENT OF DIFFUSE LARGE B-CELL LYMPHOMA

DIAGNOSIS AND MANAGEMENT OF HAIRY CELL LEUKAEMIA AND HAIRY CELL LEUKAEMIA VARIANT

MANAGEMENT AND ADMISSION TO INTENSIVE CARE OF CRITICALLY ILL ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN THE UK

DIAGNOSIS AND MANAGEMENT OF POST- TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)

INVESTIGATION AND MANAGEMENT OF TRANSIENT LEUKAEMIA OF DOWN SYNDROME (TL-DS)

DIAGNOSIS AND MANAGEMENT OF COMMON RESPIRATORY VIRAL INFECTIONS IN PATIENTS UNDERGOING TREATMENT FOR HAEMATOLOGICAL MALIGNANCIES OR STEM CELL TRANSPLANTATION

CURRENT MANAGEMENT OF NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA 

CHRONIC LYMPHOCYTIC LEUKAEMIA: ESMO & BSH CLINICAL PRACTICE GUIDELINES

USE OF IMAGING IN THE MANAGEMENT OF PATIENTS WITH MYELOMA

USE OF JAK INHIBITORS IN THE MANAGEMENT OF MYELOFIBROSIS

SCREENING AND MANAGEMENT OF LATE AND LONG-TERM CONSEQUENCES OF MYELOMA AND ITS TREATMENT

MANAGEMENT OF TUMOUR LYSIS SYNDROME IN ADULTS AND CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES

DIAGNOSIS AND MANAGEMENT OF VENO-OCCLUSIVE DISEASE (SINUSOIDAL OBSTRUCTION SYNDROME) FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION IN HAEMOPOIETIC STEM CELL TRANSPLANTATION

INVESTIGATION AND MANAGEMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

CHRONIC MYELOID LEUKAEMIA: ESMO CLINICAL PRACTICE GUIDELINES

GUIDELINES ON THE INVESTIGATION AND MANAGEMENT OF FOLLICULAR LYMPHOMA

MYELODYSPLASTIC SYNDROMES: ESMO CLINICAL PRACTICE GUIDELINES

MULTIPLE MYELOMA: ESMO CLINICAL PRACTICE GUIDELINES

THE MANAGEMENT OF PRIMARY MEDIASTINAL B‐CELL LYMPHOMA: A BRITISH SOCIETY FOR HAEMATOLOGY GOOD PRACTICE PAPER

EUROPEAN LEUKEMIANET 2020 RECOMMENDATIONS FOR TREATING CHRONIC MYELOID LEUKEMIA

INVESTIGATION AND MANAGEMENT OF ACUTE TRANSFUSION REACTIONS

USE OF IRRADIATED BLOOD COMPONENTS

HAEMATOLOGICAL MANAGEMENT OF MAJOR HAEMORRHAGE

MANAGEMENT OF ANAEMIA AND RED CELL TRANSFUSION IN ADULT CRITICALLY ILL PATIENTS

RED CELL TRANSFUSION IN SICKLE CELL DISEASE (SCD)

IDENTIFICATION AND MANAGEMENT OF PRE-OPERATIVE ANAEMIA

PLATELET TRANSFUSION

POST-TRANSFUSION PURPURA

NEONATAL ALLOIMMUNE THROMBOCYTOPENIA

SELECTING APPROPRIATE BLOOD PRODUCTS FOR RECIPIENTS OF ABO / RH MISMATCHED STEM CELL TRANSPLANTS

INVESTIGATION AND CLINICAL MANAGEMENT OF PATIENTS WITH A POSITIVE DAT WITH AND WITHOUT HAEMOLYSIS

PAROXYSMAL COLD HAEMOGLOBINURIA (PCH)

RED CELL UNIT FOR INTRAUTERINE TRANSFUSION AND EXCHANGE TRANSFUSION WITH POSITIVE DIRECT ANTIGLOBULIN TEST

GUIDELINES FOR RED CELL TRANSFUSION IN URGENT SITUATIONS AND WHEN SEROLOGICAL COMPATIBILITY CANNOT BE ASSURED

HIGH TITRE ANTI-A/B TESTING OF DONORS

INVESTIGATION AND CLINICAL MANAGEMENT OF SUSPECTED REACTIONS TO IMMUNOGLOBULIN A (IgA)

PROVISION OF RED CELL TRANSFUSION SUPPORT FOR TRANSFUSION DEPENDENT PATIENTS

DIAGNOSIS AND MANAGEMENT OF T ANTIGEN ACTIVATION

CLINICAL GUIDELINES FOR THE USE OF GRANULOCYTE TRANSFUSIONS

MANAGING PATIENTS ON MONOCLONAL ANTIBODY THERAPIES

TRANSFUSION IN THROMBASTHENIA

GUIDELINES FOR THE MANAGEMENT OF PLATELET TRANSFUSION REFRACTORINESS

TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE

GUIDELINE ON THE INVESTIGATION AND MANAGEMENT OF ACUTE TRANSFUSION REACTIONS

GUIDELINES FOR POLICIES ON ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSION. 1. PREDEPOSIT AUTOLOGOUS BLOOD DONATION AND TRANSFUSION

THE USE OF ANTI‐D IMMUNOGLOBULIN FOR THE PREVENTION OF HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN

THE ESTIMATION OF FETOMATERNAL HAEMORRHAGE

SPECTRUM OF FRESH FROZEN PLASMA AND CRYOPRECIPITATE PRODUCTS

start learning today